Dynamic DNA methylation changes in the maternal oxytocin gene locus (OXT) during pregnancy predict postpartum maternal intrusiveness.


Journal

Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 06 2018
revised: 11 01 2019
accepted: 12 01 2019
pubmed: 29 1 2019
medline: 24 4 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Maternal behavior (MB) is observable across mammals and represents an important feature of environmental variation during early postnatal development. Oxytocin (OT) plays a crucial role in MB. Even prior to childbirth, pregnancy induces epigenetic and other downstream changes in the maternal OT-system, likely mediated by the actions of steroid hormones. However, little is known about the nature and consequences of epigenetic modifications in the maternal OT-encoding gene (OXT) during pregnancy. Our study aims to investigate temporal dynamics of OXT promoter DNA methylation (DNAm) throughout pregnancy in predicting MB in humans. In 107 mother-child dyads, maternal OXT DNAm was serially analyzed in whole blood in early, mid and late pregnancy. MB was coded based on standardized mother-child interactions at six months postpartum. After controlling for cellular heterogeneity, race/ethnicity, age, and socioeconomic status, OXT-promoter DNAm exhibited a dynamic profile during pregnancy (b = 0.026, t=-3.37, p < .001), with decreases in DNAm from early to mid-pregnancy and no further change until late pregnancy. Moreover, dynamic DNAm trajectories of the OXT-promoter region predicted MB (intrusiveness) at six months postpartum (b = 0.006, t = 2.0, p < 0.05), with 6% higher OXT DNAm in late pregnancy in intrusive compared to non-intrusive mothers. We here demonstrate that OXT promoter DNAm changes significantly throughout gestation in peripheral blood and that these changes are associated with variability in MB, providing a novel potential biomarker predicting postnatal MB.

Identifiants

pubmed: 30690225
pii: S0306-4530(18)30554-7
doi: 10.1016/j.psyneuen.2019.01.013
pmc: PMC6554513
mid: NIHMS1023923
pii:
doi:

Substances chimiques

Receptors, Oxytocin 0
Oxytocin 50-56-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-162

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD060628
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH091351
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH105538
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001414
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Références

Infant Ment Health J. 2015 Jul-Aug;36(4):415-26
pubmed: 26112436
Biol Psychiatry. 2016 Feb 1;79(3):213-21
pubmed: 26208744
J Child Psychol Psychiatry. 2008 Dec;49(12):1257-69
pubmed: 18355216
Child Dev. 1991 Apr;62(2):373-84
pubmed: 2055128
Infant Ment Health J. 2005 Nov;26(6):570-597
pubmed: 28682484
New Dir Child Adolesc Dev. 2016 Sep;2016(153):73-86
pubmed: 27589499
J Psychiatr Res. 2015 Jun;65:9-15
pubmed: 25890851
J Biol Chem. 1990 Apr 15;265(11):6098-103
pubmed: 2108152
Peptides. 2007 Jun;28(6):1162-9
pubmed: 17513013
Brain Res. 1988 Aug;464(1):1-6
pubmed: 3179741
Mol Psychiatry. 2009 Oct;14(10):954-8
pubmed: 18957940
J Abnorm Child Psychol. 2016 Apr;44(3):459-70
pubmed: 26063322
Endocrinology. 2012 May;153(5):2353-61
pubmed: 22434086
J Child Psychol Psychiatry. 2011 Apr;52(4):368-97
pubmed: 20925656
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Physiol Rev. 2001 Jul;81(3):1197-267
pubmed: 11427695
Psychol Sci. 2010 Oct;21(10):1426-8
pubmed: 20855907
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Dev Psychol. 1999 Nov;35(6):1399-413
pubmed: 10563730
Neuropsychopharmacology. 2011 Dec;36(13):2603-15
pubmed: 21881566
Psychoneuroendocrinology. 2016 Jul;69:150-60
pubmed: 27108164
Nat Neurosci. 2017 Feb;20(2):287-296
pubmed: 27991897
Epigenetics Chromatin. 2015 Jan 27;8:6
pubmed: 25972926
J Comp Neurol. 2004 May 31;473(3):315-33
pubmed: 15116394
Nat Rev Genet. 2016 Aug;17(8):487-500
pubmed: 27346641
Nat Rev Neurosci. 2008 Jan;9(1):11-25
pubmed: 18073776
Nature. 2008 Mar 6;452(7183):112-5
pubmed: 18322535
J Neuroendocrinol. 2003 Aug;15(8):787-93
pubmed: 12834440
NPJ Genom Med. 2017 Apr 13;2:11
pubmed: 29263827
Philos Trans R Soc Lond B Biol Sci. 2006 Dec 29;361(1476):2199-214
pubmed: 17118933
Science. 2014 Aug 15;345(6198):771-6
pubmed: 25124431
Biol Psychiatry. 2016 Feb 1;79(3):194-202
pubmed: 26321019
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3816-23
pubmed: 27325757
Psychol Sci. 2007 Nov;18(11):965-70
pubmed: 17958710
Nature. 2008 Mar 6;452(7183):45-50
pubmed: 18322525
Horm Behav. 2016 Jan;77:204-10
pubmed: 26172856
Brain Res. 2014 Sep 11;1580:133-42
pubmed: 24184574
Ann N Y Acad Sci. 1997 Jan 15;807:126-45
pubmed: 9071347
Transl Psychiatry. 2017 Aug 1;7(8):e1187
pubmed: 28763057
Neuropsychopharmacology. 2015 May;40(6):1528-38
pubmed: 25563749
Mol Psychiatry. 2014 May;19(5):560-7
pubmed: 23689534
Child Abuse Negl. 2015 Aug;46:152-62
pubmed: 26038191
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
Biol Psychiatry. 2011 Aug 1;70(3):291-7
pubmed: 21470595
Physiol Rev. 2018 Jul 1;98(3):1805-1908
pubmed: 29897293
Child Dev. 1991 Aug;62(4):647-70
pubmed: 1935336
Nucleic Acids Res. 2017 Feb 28;45(4):e22
pubmed: 27924034
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8302-7
pubmed: 23630272

Auteurs

Philipp Toepfer (P)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Institute of Medical Psychology, Berlin, Germany.

Kieran J O'Donnell (KJ)

Ludmer Centre for Neuroinformatics and Mental Health, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada; Sackler Program for Epigenetics and Psychobiology at McGill University, Montreal, QC, Canada.

Sonja Entringer (S)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Institute of Medical Psychology, Berlin, Germany; University of California, Irvine, Development, Health, and Disease Research Program, Orange, CA, USA.

Elika Garg (E)

Ludmer Centre for Neuroinformatics and Mental Health, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.

Christine M Heim (CM)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Institute of Medical Psychology, Berlin, Germany; Department of Biobehavioral Health, Pennsylvania State University, University Park, PA, USA.

David T S Lin (DTS)

Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Julia L MacIsaac (JL)

Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Michael S Kobor (MS)

Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Michael J Meaney (MJ)

Ludmer Centre for Neuroinformatics and Mental Health, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada; Sackler Program for Epigenetics and Psychobiology at McGill University, Montreal, QC, Canada; Singapore Institute for Clinical Sciences, Singapore.

Nadine Provençal (N)

Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich, Germany; Simon Fraser University, Faculty of Health Sciences, Vancouver, BC, Canada.

Elisabeth B Binder (EB)

Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich, Germany; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.

Pathik D Wadhwa (PD)

University of California, Irvine, Development, Health, and Disease Research Program, Orange, CA, USA; Departments of Psychiatry and Human Behavior, Obstetrics and Gynecology, and Epidemiology, University of California, Irvine, School of Medicine, Irvine, CA, USA.

Claudia Buss (C)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Institute of Medical Psychology, Berlin, Germany; University of California, Irvine, Development, Health, and Disease Research Program, Orange, CA, USA. Electronic address: Claudia.buss@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH